Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-Dense CHOP-R with PEG-Filgrastim and GM-CSF in Aggressive NHL
NCT01527422Phase 2Completed
- Start
- Jan 2006
- Primary completion
- Nov 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of sargramostim, pegfilgrastim in non-Hodgkin lymphoma (NHL). Started Jan 2006; status: completed.
02
Drugs
sargramostimpegfilgrastim
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT01527422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01527422.